Status:
TERMINATED
Telehealth Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Cornell University
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Obesity, Childhood
Type2Diabetes
Eligibility:
FEMALE
12-18 years
Phase:
NA
Brief Summary
The aim of this study is to look at changes in diabetes-related risk factors in Black adolescent girls who are at risk for type 2 diabetes and their primary female caregiver after both participating i...
Detailed Description
Enrolled adolescent/caregiver dyads will participate in the 12-week program. Each week, participants will engage in 2 activities: a live virtual Wellness Session and an at-home cooking experience usin...
Eligibility Criteria
Inclusion
- Inclusion Criteria for adolescent participants:
- 12-18 years of age
- self-identify as Black or African American
- have obesity
- Exclusion Criteria of adolescent participants:
- pregnant or within 3 months postpartum.
- participated in a formal weight management program within 6 months prior to study.
- currently taking medications or diagnosed with a condition known to influence metabolism, physical activity ability, or cognitive function.
- have previously undergone bariatric surgery.
- have type 2 diabetes.
- unable to speak English or have developmental conditions that interfere with ability to communicate.
- Inclusion criteria of caregiver participants:
- 18 years or older.
- proficiency in speaking English.
- live in the same household as the adolescent who will also be enrolled
- prepares the majority (\>50%) of meals in the household
- Exclusion Criteria of caregiver participants:
- pregnant or within 3 months postpartum.
- unable to speak English or have developmental conditions that interfere with ability to communicate.
Exclusion
Key Trial Info
Start Date :
August 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 8 2025
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT05396443
Start Date
August 15 2022
End Date
February 8 2025
Last Update
March 4 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brooklyn Methodist Hospital
Brooklyn, New York, United States, 11215
2
Weill Cornell Medicine
New York, New York, United States, 10021